Biotechnology Archives

COVID-19 drug development strategies

All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.

Keys to accelerating your COVID-19 drug campaign

As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster.

How to deliver multi-product ATMP facilities for future flexibility

Manufacturers must produce a variety of ATMPs quickly and efficiently. Enter the multi-product ATMP facility.

Reducing waste with lean delivery in facility design and construction

Applying a lean delivery approach to the design and construction of new facilities can reduce waste, lower costs and improve speed to market.

NextGen Now: Delivering tomorrow’s facilities today

If cell and gene therapy products are to successfully reach patients and deliver transformative cures, then the industry will need more facilities capable of manufacturing them.

An artistic portrayal of adeno-associated viral vectors used in gene therapy manufacture

Advanced therapy medicinal product facilities through the eyes of a process architect

Advanced therapy medicinal product (ATMP) companies are ushering in a new frontier of medicine and technologies poised to revolutionize human health, but are ATMP facilities keeping up? The industry is advancing at such a rapid pace that these companies are faced with vast new complexities when developing and manufacturing their products.

A large chiller outside, which could be made more efficient with an ice storage system

How biopharma facilities can use ice in a glycol chiller system

Ice storage, coupled with a glycol chiller, can provide benefits that other options can’t.

Closing the deal: Understanding when to close your process

When to close your pharmaceutical process

Too often, the term “closed process” is thrown around without an understanding of the salient issues. Pharmaceutical process closure can certainly provide many benefits, but there are various impacts and requirements depending on the ultimate goal and the specific process you are trying to close.

To outsource or not to outsource? That is the question: How to ensure your CMO stacks up

How to choose a contract manufacturing organization

The age-old debate of whether to outsource production to a contract manufacturing organization (CMO) remains for mature, emerging and virtual biopharmaceutical companies.

Improving documentation change control process

In regulated environments, companies are expected to establish procedures for document change control as a way of ensuring product quality and safety.